Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$6K Sell
338
-120
-26% -$1.97K ﹤0.01% 1055
2023
Q3
$7K Sell
458
-13
-3% -$244 ﹤0.01% 964
2023
Q2
$10K Buy
471
+66
+16% +$1.8K ﹤0.01% 921
2023
Q1
$11K Sell
405
-544
-57% -$15.4K ﹤0.01% 804
2022
Q4
$24K Sell
949
-466
-33% -$14.2K ﹤0.01% 687
2022
Q3
$41K Sell
1,415
-812
-36% -$24K ﹤0.01% 593
2022
Q2
$56K Buy
+2,227
New +$64.2K ﹤0.01% 554

Other funds holding EMBC

Bartlett & Co's EMBC Position: Q4 2023 in Review

Bartlett & Co reduced its Embecta (EMBC) stake by 26% in Q4 2023, selling an estimated $1.97K and leaving 338 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Bartlett & Co first reported a position in EMBC in Q2 2022 and has held it in 7 quarters since. The position peaked at $56K in Q2 2022. 373 funds tracked by Wall St. Rank hold EMBC as of Q4 2023.

  • Bartlett & Co held 338 shares of Embecta worth $6K as of Q4 2023.
  • Bartlett & Co sold 120 Embecta shares in Q4 2023, an estimated $1.97K.
  • Embecta made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1055 holding.
  • Bartlett & Co first reported a position in Embecta in Q2 2022 and has held it in 7 quarters since.
  • Bartlett & Co's Embecta position peaked at $56K in Q2 2022.
  • 373 funds tracked by Wall St. Rank held Embecta as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.